FDA says Pfizer vaccine vials hold extra doses, expanding supply
Using every drop from overfilled vials could boost available doses by up to 40 percent.
Using every drop from overfilled vials could boost available doses by up to 40 percent.
An independent FDA advisory panel will meet Thursday to vote on the Moderna vaccine.
The expanded order would ensure continuous vaccine delivery through the end of June 2021, at a total cost of $3.2 billion, the Trump administration said.
Most Americans’ best hope of getting a shot by spring or early summer may rest on vaccines that have not yet been proven to work.
The expanded order would ensure continuous vaccine delivery through the end of June 2021, at a total cost of $3.2 billion, the Trump administration said.
Most Americans’ best hope of getting a shot by spring or early summer may rest on vaccines that have not yet been proven to work.
Pfizer is seeking authorization to use the vaccine in people 16 and older.
Most Americans’ best hope of getting a shot by spring or early summer may rest on vaccines that have not yet been proven to work.
Pfizer is seeking authorization to use the vaccine in people 16 and older.
Most Americans’ best hope of getting a shot by spring or early summer may rest on vaccines that have not yet been proven to work.
Most Americans’ best hope of getting a shot by spring or early summer may rest on vaccines that have not yet been proven to work.
Pfizer is seeking authorization to use the vaccine in people 16 and older.
Pfizer is seeking authorization to use the vaccine in people 16 and older.
There won’t be a coronavirus vaccine ready before Election Day, despite President Donald Trump’s repeated promises and vaccine makers’ breakneck speed.
There won’t be a coronavirus vaccine ready before Election Day, despite President Donald Trump’s repeated promises and vaccine makers’ breakneck speed.
The political backdrop could make the first coronavirus gathering of the advisory committee one of the most-watched in FDA history.
There won’t be a coronavirus vaccine ready before Election Day, despite President Donald Trump’s repeated promises and vaccine makers’ breakneck speed.
The political backdrop could make the first coronavirus gathering of the advisory committee one of the most-watched in FDA history.
There won’t be a coronavirus vaccine ready before Election Day, despite President Donald Trump’s repeated promises and vaccine makers’ breakneck speed.
The political backdrop could make the first coronavirus gathering of the advisory committee one of the most-watched in FDA history.
There won’t be a coronavirus vaccine ready before Election Day, despite President Donald Trump’s repeated promises and vaccine makers’ breakneck speed.
The political backdrop could make the first coronavirus gathering of the advisory committee one of the most-watched in FDA history.
Albert Bourla’s memo to staff asserts Pfizer’s independence in the face of strong pressure from the White House to deliver a shot before Election Day.
Albert Bourla’s memo to staff asserts Pfizer’s independence in the face of strong pressure from the White House to deliver a shot before Election Day.
Albert Bourla’s memo to staff asserts Pfizer’s independence in the face of strong pressure from the White House to deliver a shot before Election Day.
Albert Bourla’s memo to staff asserts Pfizer’s independence in the face of strong pressure from the White House to deliver a shot before Election Day.
The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to show progress on slashing drug costs.
Albert Bourla’s memo to staff asserts Pfizer’s independence in the face of strong pressure from the White House to deliver a shot before Election Day.
The Democrat-led reports come just weeks before Election Day, and amid efforts by President Donald Trump to show progress on slashing drug costs.
The reports of widespread political interference come at a critical point in the pandemic, the science and medicine academy leaders warned.